When Britain’s former vaccine tsar ran into trouble over the size of a PR bill last November, it was seized upon by critics as further evidence of the current government’s “chumocracy”. Kate Bingham is married to Treasury minister Jesse Norman, her links with Boris Johnson’s clan were shown to stretch back to Oxford (where she was a contemporary of the PM), and beyond. To the world-weary, a further allegation – that she had given away sensitive information to private investors at an investment conference – seemed par for the course.
Playing a blinder
It says something for Bingham, who has now returned to paid work in civvy street, that a legion of colleagues in finance and medicine sprang to her defence. But even detractors must now concede she has played a blinder in the race to secure the Covid-19 jab for the UK, says the Daily Mail – identifying the most promising candidates early on and then securing supplies. The current chaos in Europe is a reminder it could all have been very different. “It’s not a given that the UK – given its record – would have ended up where it is now without her,” Professor John Bell, regius professor of medicine at Oxford, told the Financial Times. “She downed tools and did the due diligence and she was really effective and… ruthless and really tough.”
A biochemist and venture capitalist, Bingham, 55, has spent three decades honing her drug discovery skills, mostly at SV Health Investors, which was spun out of Schroders in 2001 and, as of 2017, had $2bn under investment. “Think of me as being a sort of grande dame of the biotech venture community,” she says. “My entire life is saying: ‘What great new ideas are there and how can we turn them into drugs that will have a really significant impact on patients?’ It’s the world’s most exciting job.” A woman of apparently irrepressible energy, for Bingham the glass is “always half-full”, notes The Times. When the health secretary, Matt Hancock, approached her in May to build “a portfolio of coronavirus vaccines”, she knew it was going to be “incredibly difficult” because 90% of all clinical trials fail. As things turned out, the hit rate for Covid-19 vaccines “surprised everybody”, she says. “It’s just been crazy hard work, absolutely round the clock, evenings, weekends...”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The world’s 19th-best bog snorkeller
Bingham arrived at Christ Church, Oxford, precociously early at 17, at a time when the male to female ratio was 5:1, says The Guardian. Part of a college clique known, semi-ironically, as “the mafia”, she played lacrosse and partied hard, before turning “almost overnight” from “a dozy layabout” to a “rather embarrassingly keen student” in the third year and taking a first. She completed her education at Harvard Business School.
In person, Bingham has “a no-nonsense manner and a straight-talking style…rattling off facts and figures, barely pausing for breath”, says The Times. But while her stamina has been known to test the less hardy, friends point out she is a great listener, kind and generous to a fault. And whatever the challenge, Bingham throws herself in head first. One of her prouder boasts is competing in the world bog-snorkelling championships and coming 19th. Forget conjuring one of the few UK success stories in this pandemic – that’s really something to be proud of.
-
Four income funds to add to your ISAAdding one of these four income funds to your stocks and shares ISA ahead of tax year end could pay dividends
-
Are regular savings accounts worth it?A 7% interest rate is eye-catching, but how much can you save in a regular saver account and how does the interest rate work exactly?
-
Boaz Weinstein: the hedge fund ‘vulture’ swooping on the CityProfile Boaz Weinstein’s campaign to take over and transform “the Miserable Seven” London-based investment trusts has been routed – for now. The fight isn’t over yet
-
England's department stores return – but do they have a future?Opinion The great traditional retail shops of Middle England have bounced back for now. Don’t get too carried away though, says Matthew Lynn
-
Can investors stay optimistic about Russian stocks?Investors look to profit from Russia as Trump pushes for peace in Ukraine. But is it worth the risk?
-
Labour's 'Project Chainsaw' begins by abolishing NHS England – will it backfire?Keir Starmer is taking the fight to the blockers, the NIMBYs, public sector workers and the unions says Emily Hohler. What happens if Labour fails to deliver?
-
Zhang Shengwei: the godfather of the vape industryProfile Zhang Shengwei quietly grew his online vape shop and now gives Big Tobacco a run for its money. Can he survive the backlash from regulators?
-
The benefits of a stock bubbleOpinion We tend to think of stock bubbles as bad things but, as the dotcom craze shows, good things can come from them, says Matthew Lynn
-
Friedrich Merz proposes 'radical' spending package for GermanyGermany's chancellor designate Friedrich Merz wants to scrap restraints on borrowing and allow for much higher defence spending
-
Walgreens Boots Alliance sold to private equity firm - will Boots get the boot?US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?
